Vascutek limb salvage device cleared
This article was originally published in The Gray Sheet
Executive Summary
Temporary Limb Salvage Shunt gains FDA market clearance following less than a week of review. The agency cites the "critical need for such a device" and applicability to combat situations in announcing the clearance Feb. 9. The shunt bridges severed blood vessels to maintain blood flow to injured limbs while patients are transported to surgical facilities. The first-of-its-kind shunt features a self-sealing elastomer that allows for injection of drugs. "This device has been used successfully by other countries and is particularly important to serve our men and women in the Armed Forces who are seriously injured in combat," stated CDRH Director Dan Schultz...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.